May 4, 2020 / 1:09 PM / a month ago

BRIEF-Mallinckrodt Announces Positive Findings In Inomax Gas

May 4 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT ANNOUNCES POSITIVE FINDINGS IN INOMAX® (NITRIC OXIDE) GAS, FOR INHALATION PHASE 4 OBSERVATIONAL REGISTRY IN NEONATES WITH PULMONARY HYPERTENSION; ENDS TRIAL EARLY

* MALLINCKRODT PLC - ENDED PHASE 4 OBSERVATIONAL REGISTRY EARLY DUE TO ACHIEVEMENT OF PRE-SPECIFIED PRIMARY OUTCOME MEASURE, NON-INFERIORITY

* MALLINCKRODT PLC - NO DRUG-RELATED SERIOUS ADVERSE EVENTS WERE ATTRIBUTED TO STUDY DRUG

* MALLINCKRODT PLC - DUE TO SERIOUSNESS OF CONDITION, A RANDOMIZED CONTROLLED TRIAL CANNOT BE CONDUCTED IN THE PRE-TERM NEONATE POPULATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below